These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25760233)

  • 1. Identification and function analysis of contrary genes in Dupuytren's contracture.
    Ji X; Tian F; Tian L
    Mol Med Rep; 2015 Jul; 12(1):482-8. PubMed ID: 25760233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of candidate genes in fibroblasts derived from patients with Dupuytren's contracture using bioinformatics analysis.
    Liu H; Yin W; Liu B; Liu Y; Guo B; Wei Z
    Rheumatol Int; 2015 Aug; 35(8):1343-50. PubMed ID: 25963801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis to identify novel diagnostic and therapeutic targets for Dupuytren's disease.
    Park TH; Kim D; Lee YS; Kim SY
    Wound Repair Regen; 2020 Mar; 28(2):202-210. PubMed ID: 31688987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-protein interaction network and significant gene analysis of osteoporosis.
    Wu XM; Ma X; Tang C; Xie KN; Liu J; Guo W; Yan YL; Shen GH; Luo EP
    Genet Mol Res; 2013 Oct; 12(4):4751-9. PubMed ID: 24222250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA
    Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key genes and crucial modules associated with coronary artery disease by bioinformatics analysis.
    Zhang X; Cheng X; Liu H; Zheng C; Rao K; Fang Y; Zhou H; Xiong S
    Int J Mol Med; 2014 Sep; 34(3):863-9. PubMed ID: 24969630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture.
    Satish L; LaFramboise WA; O'Gorman DB; Johnson S; Janto B; Gan BS; Baratz ME; Hu FZ; Post JC; Ehrlich GD; Kathju S
    BMC Med Genomics; 2008 Apr; 1():10. PubMed ID: 18433489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human prolactinoma related genes by DNA microarray.
    Zhao L; Lin M; Wang S
    J Cancer Res Ther; 2014; 10(3):544-8. PubMed ID: 25313736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture.
    Seyhan H; Kopp J; Schultze-Mosgau S; Horch RE
    Plast Reconstr Surg; 2006 Apr; 117(4):1248-52. PubMed ID: 16582795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts.
    Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
    J Hand Surg Eur Vol; 2009 Dec; 34(6):783-7. PubMed ID: 19786408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.